alexa Shall We Consider DPP-4-Inhibitors as Cardiovascular Sa
ISSN: 2572-5629

Diabetes Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Opinion Article

Shall We Consider DPP-4-Inhibitors as Cardiovascular Safe Drugs?

Jose Mario F de Oliveira*

Department of Medicine, Universidade Federal Fluminense, Brazil

*Corresponding Author:
Jose Mario F de Oliveira
Department of Medicine
Universidade Federal Fluminense, Brazil
Tel: +55212629-9208
E-mail: [email protected]

Received date: August 08, 2016; Accepted date: August 26, 2016; Published date: August 28, 2016

Citation: de Oliveira JMF (2016) Shall We Consider DPP-4-Inhibitors as Cardiovascular Safe Drugs? Diabetes Case Rep 1:111.

Copyright: © 2016 de Oliveira JMF. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Cardiovascular diseases are by far the most frequent and deadly complications of type 2 diabetes mellitus. All recent anti-diabetic drugs have been shadowed by signals of more or less severe toxic side-effects, but the DPP-4 Inhibitors (DPP-4) have been gaining the reputation, based on interpretations of short and medium-term randomized clinical trials (RCT), and to pre-marketing rules of regulatory agencies, of being as a whole safe anti-diabetic drugs for type 2 diabetics.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version